Search all trials

Find therapies in clinical trials near you – page 42

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Anaemia+1

Recruiting

Registered drugNo placebo

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Elritercept

Contact Research Centre

Ovarian cancer

Recruiting

Registered drugNo placebo

Phase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:INCB123667

Contact Research Centre

Crohn's disease

Recruiting

InvestigationalNo placebo

One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease

InvestigationalNo placebo

France

Participants:18–64 years
Substances:Guselkumab

Contact Research Centre

Back pain

Recruiting

Registered drug

Efficacy and tolerability of diclofenac potassium + thiocolchicoside versus diclofenac potassium in patients with acute severe low back pain

Registered drug

Cyprus

Participants:18–64 years · 65+ years
Substances:DICLOFENAC POTASSIUM

Contact Research Centre

B-cell type acute leukaemia

Recruiting

Registered drugNo placebo

Optimizing fludarabine phosphate exposure to improve event‑free survival in children and young adults with B‑cell acute lymphoblastic leukemia receiving CAR‑T therapy

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Fludarabine Phosphate

Contact Research Centre

Neoplasm malignant+1

Recruiting

Registered drugNo placebo

Anti‑PD1 Therapy with pembrolizumab and cemiplimab in first‑line advanced non‑small cell lung cancer patients with high PD‑L1 expression

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Neoplasm malignant+1

Recruiting

Registered drugNo placebo

A Phase I/II Study of GVV858 Alone or in Drug Combination for Patients with Advanced Hormone Receptor‑Positive, HER2‑Negative Breast Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Diffuse large B-cell lymphoma refractory+1

Recruiting

Registered drugNo placebo

Glofitamab plus drug combination for relapsed/refractory large B‑cell lymphoma in high‑risk second‑line patients eligible for CAR‑T therapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Glofitamab

Contact Research Centre

Hypochondroplasia

Recruiting

InvestigationalNo placebo

Long‑Term Safety and Efficacy of Infigratinib in Children with Hypochondroplasia

InvestigationalNo placebo

Norway

Participants:0–17 years
Substances:Infigratinib

Contact Research Centre

Acute myeloid leukaemia refractory+2

Recruiting

InvestigationalNo placebo

Phase 1/2 Study of LB-208 in Adults with Relapsed or Refractory Acute Myeloid Leukaemia and High‑Risk Myelodysplastic Syndrome

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Rett syndrome

Recruiting

Registered drug

A Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome

Registered drug

Belgium

Participants:0–17 years · 18–64 years
Substances:Fenfluramine Hydrochloride

Contact Research Centre

Small cell lung cancer metastatic

Recruiting

InvestigationalNo placebo

Phase II Study of Intravenous Tarlatamab for Patients with Asymptomatic Brain Metastases from Small Cell Lung Cancer

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Tarlatamab

Contact Research Centre

Find therapies in clinical trials near you – page 42

3 961 trials match your criteria

Anaemia+1

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Ovarian cancer

Phase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression

Crohn's disease

One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease

Back pain

Efficacy and tolerability of diclofenac potassium + thiocolchicoside versus diclofenac potassium in patients with acute severe low back pain

B-cell type acute leukaemia

Optimizing fludarabine phosphate exposure to improve event‑free survival in children and young adults with B‑cell acute lymphoblastic leukemia receiving CAR‑T therapy

Neoplasm malignant+1

Anti‑PD1 Therapy with pembrolizumab and cemiplimab in first‑line advanced non‑small cell lung cancer patients with high PD‑L1 expression

Neoplasm malignant+1

A Phase I/II Study of GVV858 Alone or in Drug Combination for Patients with Advanced Hormone Receptor‑Positive, HER2‑Negative Breast Cancer

Diffuse large B-cell lymphoma refractory+1

Glofitamab plus drug combination for relapsed/refractory large B‑cell lymphoma in high‑risk second‑line patients eligible for CAR‑T therapy

Hypochondroplasia

Long‑Term Safety and Efficacy of Infigratinib in Children with Hypochondroplasia

Acute myeloid leukaemia refractory+2

Phase 1/2 Study of LB-208 in Adults with Relapsed or Refractory Acute Myeloid Leukaemia and High‑Risk Myelodysplastic Syndrome

Rett syndrome

A Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome

Small cell lung cancer metastatic

Phase II Study of Intravenous Tarlatamab for Patients with Asymptomatic Brain Metastases from Small Cell Lung Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.